ArticleJACS Au2023
Photoinduced
Article in JACS Au, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Recent Advances in Dual Palladium Photoredox Catalysis.Chemistry, an Asian journal · 2026Review
- A unified strategy for remote C-H fluorination of phenylacetic acids and their homologues at theChemical science · 2026Article
- Photoinduced Ruthenium-CatalyzedACS catalysis · 2025Article
- Photocatalytic regioselective C-H bond functionalizations in arenes.Chemical science · 2025Review
- Article
- Redox-Neutral Decarboxylative Cross-Coupling of Oxamates with Aryl Bromides.ACS organic & inorganic Au · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The merger of photocatalysis and transition-metal catalysis has recently emerged as an adaptable platform for the development of innovative and environmentally benign synthetic methodologies. In contrast to classical transformation by Pd complexes, photoredox Pd catalysis operates through a radical pathway in the absence of a radical initiator. Using the synergistic merger of photoredox and Pd catalysis, we have developed a highly efficient, regioselective, and general
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.